One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Digital PCR (dpcr) and Real-Time PCR (qpcr) Market

[ 英語タイトル ] Digital PCR (dpcr) and Real-Time PCR (qpcr) Market - Global Outlook and Forecast 2020-2025

Product Code : ATHC00106085
Survey : Arizton
Publish On : March, 2021
Number of Pages : 262
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD3500 / Question Form
5 User USD4000 / Question Form
Enterprise User USD5000 / Question Form

Prominent Vendors
• Agilent Technologies Inc.
• Quidel
• Takara Bio
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Danaher
• F.Hoffmann-La Roche

Other Prominent Vendors
• Abbott
• BD
• bioMérieux
• Convergent Technologies
• Promega
• Analytik Jena AG
• Meridian Bioscience
• Eppendorf
• Enzo Life Sciences
• ELITechGroup
• Quantabio
• Sacace Biotechnologies
• Bio Molecular Systems
• Biomeme
• JN Medsys
• Anitoa Systems
• ACTGene
• Mylab Discovery Solutions
• Amplyus
• Blue-Ray Biotech
• PentaBase
• Hologic
• GenMark Diagnostics
• Luminex
• Mobidiag
• PathoFinder
• Acupath Laboratories
• Altona Diagnostics
• BioCore
• Fosun Pharma
• General Biologicals Corporation (GBC)
• GeneStore
• Gnomegen
• KogeneBiotech

[Report Description]

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global dPCR and qPCR Market Report

The dPCR and qPCR market by revenue is expected to grow at a CAGR of over 9% during the period 2020–2025.

The global digital PCR (dPCR) and the real-time PCR (qPCR) market is one of the dynamic and fast-growing segments in the diagnostic and life sciences industries. The dPCR and qPCR market is growing at a significant rate due to the rising incidence of infectious diseases and genetic disorders, continuous technological advancements in PCR technologies, the successful completion of the human genome project, and increasing R&D investments, funds, and grants as well as the increasing use of biomarker profiling for disease diagnostics. The surge in the growth can also be attributed to the growing prevalence/incidence of epidemics and pandemics such as the COVID-19 pandemic.

The introduction of automated analyzers with advanced connectivity, and high throughput, with reduced waiting time and portability, the increase in the accuracy of the devices with the usage of the PCR specific test kits, ability to perform the large volume of tests in a shorter duration of time are expected to influence the market. Moreover, continued efforts by manufacturers to develop novel dPCR and qPCR systems and kits to use in molecular testing are likely to further propel the growth of the dPCR and qPCR market. New systems are expected to offer highly automated workflows and quick turnaround times than the current digital PCR platforms, which are likely to provide a significant competitive advantage.

The following factors are likely to contribute to the growth of the dPCR and qPCR market during the forecast period:
• Surge in Demand for PCR Tests due to COVID-19
• Increase in Demand for POC PCR Diagnostics
• Prevalence of Infectious Disease and Genetic Disorder
• Advances in PCR Technology
The study considers the present scenario of the dPCR and qPCR market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Global dPCR and qPCR Market Segmentation

In 2019, the Real-time PCR (qPCR) segment dominated the market and accounted for a share of over 90%. One of the major reasons for the dominance of qPCRs is that they are widely used in infectious disease diagnosis and research projects. Real-time PCRs (qPCRs) have been well-established as credible and capable technology and are relied upon by researchers for their speed, sensitivity, specificity, and convenience. Several laboratories in developing countries are upgraded their infrastructure and technical training to perform PCR-based diagnosis for infectious diseases, thereby driving the segment growth.

The usage of a wide array of several standard reagents and test kits to perform several PCR-based tests is a major factor responsible for the growth of the consumable segment. The usage of consumables is reoccurring in nature, which is generating continuous revenue for vendors. Therefore, several renowned vendors are manufacturing consumables for PCR instruments. In recent years, the demand for consumables is increasing at a significant rate; hence, vendors are offering a wide array of reagents and other associated consumables to perform a range of procedures. Both global and local/regional players are offering a diverse range of consumables catering to the end-users requirements. The high prevalence of several infectious diseases across the globe has increased the demand for PCRs.

The clinical end-user segment dominates the market as PCRs play a significant role in the detection of DNA methylation, recognition of viruses and protozoa in infectious diseases, estimation of gene copy number aberrations, and primer extension. The application of qPCR is high in the clinical application end-user segment due to the high cost of dPCR. As real-time PCR assays offer immediate results for the detection of bacteria, clinicians can confirm the infection status of the patient more rapidly than culture methods, allowing more specific and timely administration of appropriate therapy. The research application segment is limited to users in developed countries. The segment accounted for a share of over 44% in the global dPCR and qPCR market. Gene expression, genotyping, sequencing cloning, mutagenesis, and methylation are the major applications for PCRs in the research segment.

Diagnostic laboratories are the largest end-user of PCR instruments and consumables than other segments. They use PCR instruments for diagnosis purposes. Commercial and public health laboratories prefer the latest diagnostic equipment. Their investment focuses on advanced equipment for accurate results to attract customers. Private laboratories have expanded their footprints, especially in developing countries, which has stimulated the growth prospects. Moreover, the demand for standalone reference laboratories is growing gradually owing to the prevalence of pandemic conditions, or the outbreak of unexpected infectious diseases, requiring immediate diagnosis of the diseases for the large population in a shorter period.
By Product
• Systems/Analyzers & Software
• Consumables
By Application
• Clinical
• Research
• Forensic
By Technology
• Real-Time PCR
• Digital PCR
By End-user
• Hospitals
• Diagnostic Laboratories
• Research Laboratories
• Pharma & Biotech Companies
• Forensic Laboratories
• Others

Insights By Geography

In 2019, North America accounted for a market share of 45% of the global digital PCR (dPCR) and real-time PCR (qPCR) market. Several factors are responsible for the growth of the market in the region. However, the increase in the target population and the high incidence of several infectious disease diagnostics are driving the PCR demand. There has been increasing in the prevalence of sexually transmitted diseases in North America. In 2018, over 37,832 people were confirmed HIV positive in the US and other states. A significant increase in several infectious diseases such as hepatitis, TB, and HIV was reported in the US alone. Approximately every 3 minutes, one person in the US is diagnosed with blood cancer. An estimated 176,200 people in the United States are diagnosed with leukemia, lymphoma, or myeloma in 2019. The government expenditure on clinical diagnostics & laboratory services has grown by 3% during the period 2010–2017, reaching $96.6 billion. Advances in technology are likely to increase the role of PCR tests in detecting, treating, and monitoring diseases. PCR is widely used in hospital setups as the conventional technique of culture-based disease diagnosis requires long isolation time and hospital admission.

By Geography
• North America
o US
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
• Asia Pacific
o China
o Japan
o South Korea
o Australia
o India
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o Turkey

Insights By Vendors

The global Digital PCR (dPCR) and Real-time PCR (qPCR) market is highly dynamic with the presence of global, regional, and local players, offering a diverse range of analyzers, software, and reagents for end-users. Agilent Technologies, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, QIAGEN, Takara Biotech, and Thermo Fisher Scientific are the key players operating in the global dPCR and qPCR market. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio. Manufacturers are continuously focusing on product launches & development and offering PCR instruments and software with new features to increase their market presence.

Vendors are focusing on developing and commercializing innovative analyzers, dPCR, COVID-19 PCR rapid test kits, and consumables to remain competitive and gain a significant presence in the market. New product approvals/launches coupled with R&D activities help vendors to expand their presence, enhance market growth during the forecast period, and sustain their market position in the global qPCR and dPCR market.

Prominent Vendors
• Agilent Technologies Inc.
• Quidel
• Takara Bio
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Danaher
• F.Hoffmann-La Roche

Other Prominent Vendors
• Abbott
• BD
• bioMérieux
• Convergent Technologies
• Promega
• Analytik Jena AG
• Meridian Bioscience
• Eppendorf
• Enzo Life Sciences
• ELITechGroup
• Quantabio
• Sacace Biotechnologies
• Bio Molecular Systems
• Biomeme
• JN Medsys
• Anitoa Systems
• ACTGene
• Mylab Discovery Solutions
• Amplyus
• Blue-Ray Biotech
• PentaBase
• Hologic
• GenMark Diagnostics
• Luminex
• Mobidiag
• PathoFinder
• Acupath Laboratories
• Altona Diagnostics
• BioCore
• Fosun Pharma
• General Biologicals Corporation (GBC)
• GeneStore
• Gnomegen
• KogeneBiotech

Key Questions Answered:
1. What is the Digital PCR (dPCR) and Real-time PCR (qPCR) market size in 2020?
2. What are the factors impacting the growth of the dPCR and qPCR market share?
3. What is the growth of the digital PCR market?
4. Who are the leading vendors in the dPCR and qPCR market, and what are their market share?
5. What is the impact of the COVID-19 pandemic on the dPCR and qPCR market share?

1 Research Methodology
2 Research Objectives
3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.3.1 Market Segmentation by Technology
4.3.2 Market Segmentation by Product
4.3.3 Market Segmentation by Application
4.3.4 Market Segmentation by End-User
4.3.5 Market Segmentation by Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Evolution of PCR
7.2 COVID-19 Pandemic
7.2.1 Overview

8 Market Opportunities & Trends
8.1 Surge In The Demand For PCR Tests Due To Covid-19
8.2 Increase In The Demand For Point-Of-Care (POC) PCR Diagnostics
8.3 Paradigm Shift Towards The Usage Of dPCR

9 Market Growth Enablers
9.1 Increase In The Prevalence Of Infectious Diseases And Genetic Disorders
9.2 Technological Advancements In PCR
9.3 Expanding Application Of PCR Post Human Genome Project

10 Market Restraints
10.1 Technical Limitations Of PCR
10.2 High Cost Of PCR
10.3 Low Penetration Of PCR Instruments In LMICs

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry

12 Technology
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Real-Time PCR
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Digital PCR
12.4.1 Market Overview
12.4.2 Market Size & Forecast

13 Product
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Consumables
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Systems/Analyzers & Software
13.4.1 Market Overview
13.4.2 Market Size & Forecast

14 Application
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Clinical Applications
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Research Applications
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 Forensic Applications
14.5.1 Market Overview
14.5.2 Market Size & Forecast

15 End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Diagnostic Laboratories
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Hospitals
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Research Laboratories
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Pharma & Biotech Companies
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.7 Forensic Laboratories
15.7.1 Market Overview
15.7.2 Market Size & Forecast
15.8 Others
15.8.1 Market Overview
15.8.2 Market Size & Forecast

16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview

17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 US: Market Size & Forecast
17.3.2 Canada: Market Size & Forecast

18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Germany: Market Size & Forecast
18.3.2 France: Market Size & Forecast
18.3.3 UK: Market Size & Forecast
18.3.4 Italy: Market Size & Forecast
18.3.5 Spain: Market Size & Forecast

19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Japan: Market Size & Forecast
19.3.2 China: Market Size & Forecast
19.3.3 Australia: Market Size & Forecast
19.3.4 South Korea: Market Size & Forecast
19.3.5 India: Market Size & Forecast

20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Brazil : Market Size & Forecast
20.3.2 Mexico: Market Size & Forecast
20.3.3 Argentina: Market Size & Forecast

21 Middle East And Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Key Countries
21.3.1 Turkey: Market Size & Forecast
21.3.2 Saudi Arabia: Market Size & Forecast
21.3.3 South Africa: Market Size & Forecast
21.3.4 UAE: Market Size & Forecast

22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Agilent Technologies
22.2.2 Bio-Rad Laboratories
22.2.3 Danaher
22.2.4 F. Hoffmann-La Roche
22.2.5 Quidel
22.2.6 Qiagen
22.2.7 Takara Bio
22.2.8 Thermo Fisher Scientific

23 Key Company Profiles
23.1 Agilent Technologies
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 Quidel
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 Qiagen
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 Takara Bio
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Thermo Fisher Scientific
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 Bio-Rad Laboratories
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.6.5 Key Opportunities
23.7 Danaher
23.7.1 Business Overview
23.7.2 Product Offerings
23.7.3 Key Strategies
23.7.4 Key Strengths
23.7.5 Key Opportunities
23.8 F. Hoffmann-La Roche
23.8.1 Business Overview
23.8.2 Product Offerings
23.8.3 Key Strategies
23.8.4 Key Strengths
23.8.5 Key Opportunities

24 Other Prominent Vendors
24.1 Abbott
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 BD
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 bioMérieux
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Convergent Technologies
24.4.1 Business Overview
24.4.2 Product Offerings
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Promega
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Analytik Jena Group
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 Meridian Bioscience
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 Eppendorf
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Enzo Life Sciences
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Bioneer
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 ELITechGroup
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 Quantabio
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 SACACE Biotechnologies
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Bio Molecular Systems
24.15.1 Business Overview
24.15.2 Product Offerings
24.16 Biomeme
24.16.1 Business Overview
24.16.2 Product Offerings
24.17 JN Medsys
24.17.1 Business Overview
24.17.2 Product Offerings
24.18 Anitoa Systems
24.18.1 Business Overview
24.18.2 Product Offerings
24.19 ACTGene
24.19.1 Business Overview
24.19.2 Product Offerings
24.20 Mylab Discovery Solutions
24.20.1 Business Overview
24.20.2 Product Offerings
24.21 Amplyus
24.21.1 Business Overview
24.21.2 Product Offerings
24.22 Blue-Ray Biotech
24.22.1 Business Overview
24.22.2 Product Offerings
24.23 PentaBase
24.23.1 Business Overview
24.23.2 Product Offerings
24.24 Hologic
24.24.1 Business Overview
24.24.2 Product Offerings
24.25 GenMark Diagnostics
24.25.1 Business Overview
24.25.2 Product Offerings
24.26 Luminex
24.26.1 Business Overview
24.26.2 Product Offerings
24.27 Mobidiag
24.27.1 Business Overview
24.27.2 Product Offerings
24.28 PathoFinder
24.28.1 Business Overview
24.28.2 Product Offerings
24.29 Acupath Laboratories
24.29.1 Business Overview
24.29.2 Product Offerings
24.30 ALTRU Diagnostics
24.30.1 Business Overview
24.30.2 Product Offerings
24.31 Altona Diagnostics
24.31.1 Business Overview
24.31.2 Product Offerings
24.32 BGI
24.32.1 Business Overview
24.32.2 Product Offerings
24.33 BioCore
24.33.1 Business Overview
24.33.2 Product Offerings
24.34 Fosun Pharma
24.34.1 Business Overview
24.34.2 Product Offerings
24.35 GenerAl Biologicals
24.35.1 Business Overview
24.35.2 Product Offerings
24.36 GeneStore
24.36.1 Business Overview
24.36.2 Product Offerings
24.37 Gnomegen
24.37.1 Business Overview
24.37.2 Product Offerings
24.38 KogeneBiotech
24.38.1 Business Overview
24.38.2 Product Offerings

25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations

26 Quantitative Summary
26.1 Market By Geography
26.2 Market By End-User
26.3 Market By Technology
26.4 Market By Product
26.5 Market By Application

27 Appendix
27.1 Abbreviations



Recommended reports